IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Curis Lifesciences Ltd.
Issue Open Date 07-Nov-25  
Issue Closing Date 11-Nov-25  
Application Money 100  
Allotment Money  
Price Band 120 - 128  
Minimium Application No. 2000  
Issue Size (Shares) 1541000  
Market Lot 1.00  
Objective
i.Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities;ii.Capital Expenditure towards Construction of a Storage Facility;iii.Pre-payment/Repayment of outstanding Secured Loans;iv.Product Registrations in other countries;v.Funding our Working Capital Requirements; andvi.General Corporate Purpose.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     35671000   NA  
Qualified Institutional Buyers     39335000   NA  
Retail Individual Investors     31706000   NA  
Business Description
Our business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic onloan license or contract Manufacturing and own brand marketing basis. Our business is majorly on principle to principlebasis with different
more...
Promoter's Holding
Total Share Capital   5500000  
Offered to Public   1541000  
Promoter's Holding (Pre-Issue)   92.68  
Promoter's Holding (Post-Issue)   68.03  
Address
P F-23
G I D C
Sanand - I I
Industrial Estate
Sanand
Ahmedabad ,
Gujarat ,
382110
Phone: 7096558558
Email: info@curisls.com
Website: www.curisls.com
Registrar
MUFG Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
NSE
Lead Manager
Finaax Capital Advisors Pvt Ltd
Promoters
Dharmesh Dashrathbhai Patel
Jaimik Mansukhbhai Patel
Piyush Gordhanbhai Antala
Siddhant Jayantibhai Pawasia
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.